OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 312
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 312
Showing 1-25 of 312 citing articles:
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 191
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 191
Current and promising applications of Hf(iv )-based MOFs in clinical cancer therapy
Xuelin Chen, Minmin Li, Mingzi Lin, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 25, pp. 5693-5714
Closed Access | Times Cited: 78
Xuelin Chen, Minmin Li, Mingzi Lin, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 25, pp. 5693-5714
Closed Access | Times Cited: 78
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 50
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 50
X‐ray‐Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy
Nanhui Liu, Junjie Zhu, Wenjun Zhu, et al.
Advanced Materials (2023) Vol. 35, Iss. 29
Closed Access | Times Cited: 48
Nanhui Liu, Junjie Zhu, Wenjun Zhu, et al.
Advanced Materials (2023) Vol. 35, Iss. 29
Closed Access | Times Cited: 48
The pleiotropic functions of reactive oxygen species in cancer
Katherine Wu, Ahmed E. El Zowalaty, Volkan I. Sayin, et al.
Nature Cancer (2024) Vol. 5, Iss. 3, pp. 384-399
Closed Access | Times Cited: 40
Katherine Wu, Ahmed E. El Zowalaty, Volkan I. Sayin, et al.
Nature Cancer (2024) Vol. 5, Iss. 3, pp. 384-399
Closed Access | Times Cited: 40
Tantalum–Zirconium Co‐Doped Metal–Organic Frameworks Sequentially Sensitize Radio–Radiodynamic–Immunotherapy for Metastatic Osteosarcoma
Tao Li, Mingquan Gao, Zifei Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 39
Tao Li, Mingquan Gao, Zifei Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 39
Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 23
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 23
A Hybrid Nanoadjuvant Simultaneously Depresses PD‐L1/TGF‐β1 and Activates cGAS‐STING Pathway to Overcome Radio‐Immunotherapy Resistance
Lei Yi, Xin Jiang, Zaigang Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 18
Lei Yi, Xin Jiang, Zaigang Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 18
Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics
Zhaoyi Ye, Ying Bao, Zefeng Chen, et al.
Coordination Chemistry Reviews (2024) Vol. 504, pp. 215654-215654
Closed Access | Times Cited: 13
Zhaoyi Ye, Ying Bao, Zefeng Chen, et al.
Coordination Chemistry Reviews (2024) Vol. 504, pp. 215654-215654
Closed Access | Times Cited: 13
Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
Nuo-Han Wang, Zheng Lei, Hao-Nan Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1406-1406
Open Access | Times Cited: 39
Nuo-Han Wang, Zheng Lei, Hao-Nan Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1406-1406
Open Access | Times Cited: 39
mRNA Cancer Vaccines: Construction and Boosting Strategies
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 34
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 34
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
Lusine Hovhannisyan, Carsten Riether, Daniel M. Aebersold, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Lusine Hovhannisyan, Carsten Riether, Daniel M. Aebersold, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 32
MRI-LINAC: A transformative technology in radiation oncology
John Ng, Fabiana Gregucci, Ryan Pennell, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 28
John Ng, Fabiana Gregucci, Ryan Pennell, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 28
Immunotargeting of Cancer Stem Cells
Ayşe Sedef Köseer, Simona Di Gaetano, Claudia Arndt, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1608-1608
Open Access | Times Cited: 26
Ayşe Sedef Köseer, Simona Di Gaetano, Claudia Arndt, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1608-1608
Open Access | Times Cited: 26
“Reinforcement” by Tumor Microenvironment: The Seventh “R” of Radiobiology
Farzad Taghizadeh‐Hesary
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 119, Iss. 3, pp. 727-733
Closed Access | Times Cited: 24
Farzad Taghizadeh‐Hesary
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 119, Iss. 3, pp. 727-733
Closed Access | Times Cited: 24
Therapeutic Vaccination for HPV-Mediated Cancers
Flora Yan, Lindsay G. Cowell, Anna Tomkies, et al.
Current Otorhinolaryngology Reports (2023) Vol. 11, Iss. 1, pp. 44-61
Open Access | Times Cited: 20
Flora Yan, Lindsay G. Cowell, Anna Tomkies, et al.
Current Otorhinolaryngology Reports (2023) Vol. 11, Iss. 1, pp. 44-61
Open Access | Times Cited: 20
Particle radiotherapy in the era of radioimmunotherapy
Zihan Zhou, Bingjie Guan, Huang Xia, et al.
Cancer Letters (2023) Vol. 567, pp. 216268-216268
Closed Access | Times Cited: 19
Zihan Zhou, Bingjie Guan, Huang Xia, et al.
Cancer Letters (2023) Vol. 567, pp. 216268-216268
Closed Access | Times Cited: 19
Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases
Zhongyan Wang, Hongjing Luo, Heping Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 10
Zhongyan Wang, Hongjing Luo, Heping Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 10
Health Effects of Ionizing Radiation on the Human Body
Jasminka Talapko, Domagoj Talapko, Darko Katalinić, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 653-653
Open Access | Times Cited: 10
Jasminka Talapko, Domagoj Talapko, Darko Katalinić, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 653-653
Open Access | Times Cited: 10
Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment
Junyu Qiu, Zilin Cheng, Zheng Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5490-5490
Open Access | Times Cited: 10
Junyu Qiu, Zilin Cheng, Zheng Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5490-5490
Open Access | Times Cited: 10
Immune checkpoint inhibitors: breakthroughs in cancer treatment
Xueqing Kong, Jinyi Zhang, Shuwei Chen, et al.
Cancer Biology and Medicine (2024), pp. 1-11
Open Access | Times Cited: 9
Xueqing Kong, Jinyi Zhang, Shuwei Chen, et al.
Cancer Biology and Medicine (2024), pp. 1-11
Open Access | Times Cited: 9
Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review
Saurav Verma, Sympascho Young, Gabriel Boldt, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1422-1434
Open Access | Times Cited: 8
Saurav Verma, Sympascho Young, Gabriel Boldt, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1422-1434
Open Access | Times Cited: 8
Pyroptotic cell death: an emerging therapeutic opportunity for radiotherapy
Hongbin Li, Tiantian Yang, Jialin Zhang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Hongbin Li, Tiantian Yang, Jialin Zhang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings
Daniel Park, Won Jin Jeon, Chieh Yang, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 318-318
Open Access | Times Cited: 7
Daniel Park, Won Jin Jeon, Chieh Yang, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 318-318
Open Access | Times Cited: 7
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 7
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 7
